The tetraspanins CD63, CD81 and CD9 are commonly used as surface markers of EVs, but are ubiquitously expressed (Maecker et al., 1997) and cannot differentiate EVs that are released by cancer cells and by normal cells. Here, CD9 is linked to cancer.